Skip to main content

Advertisement

Log in

The Edmonton Obesity Staging System Predicts Perioperative Complications and Procedure Choice in Obesity and Metabolic Surgery—a German Nationwide Register-Based Cohort Study (StuDoQ|MBE)

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Objective

To examine the relationship between Edmonton Obesity Staging System (EOSS) and perioperative complications as well as surgical procedure.

Background

The application of EOSS for the selection of patients with obesity is a more comprehensive measure of obesity-related diseases and a predictor of mortality than body mass index (BMI).

Methods

This was a nationwide cohort study using prospectively inserted data from the German register for obesity and metabolic surgery StuDoQ|MBE. All patients undergoing sleeve gastrectomy (SG), Roux-en Y gastric bypass (RYGB), and one-anastomosis gastric bypass (OAGB) between February 2015 and July 2017 as a primary treatment for severe obesity were included. Data included gender, age, BMI, ASA score, EOSS, early postoperative complications next to the Clavien-Dindo grading system, readmission, and 30-day mortality.

Results

A total of 9437 patients were included. The mean BMI was 49.5 kg/m2 ± 7.8 (range 35–103.5). The total postoperative complication rate was 5.3%, with the highest rate in EOSS 3 (7.8%) and 4 (6.8%). Thirty-day mortality was 0.2% with the highest mortality after SG in EOSS 3 (1.16%) and EOSS 4 (0.92%) (p = 0.0068). Crosstabs showed a prevalence of Clavien-Dindo III and IV complications of 3.4% (SG), 3.6% (RYGB), and 1.6% (OAGB) in EOSS 2 (p = 0.0032) and 3.5% (SG), 5.1% (RYGB), and 5.6% (OAGB) in EOSS 3.

Conclusion

The highest postoperative complications and mortality occurred in patients with EOSS ≥ 3. SG and OAGB could be the procedure of choice to reduce perioperative morbidity; nevertheless, it has to be in mind that in EOSS ≥ 3, SG has the highest mortality.

Trial Registration

ClinicalTrials.gov Identifier NCT03556059.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

EOSS:

Edmonton Obesity Staging System

T2DM:

Type 2 diabetes mellitus

SG:

Sleeve gastrectomy

RYGB:

Roux-en-Y gastric bypass

OAGB:

One-anastomosis gastric bypass

SD:

Standard deviation

GERD:

Gastroesophageal reflux disease

ASA:

American Society of Anesthesiologists

MAS:

Metabolic acuity score

OSAS:

Obstructive sleep apnea syndrome

References

  1. De Luca M, Angrisani L, Himpens J, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2016;26(8):1659–96.

    Article  Google Scholar 

  2. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes. 2009;33(3):289–95.

    Article  CAS  Google Scholar 

  3. Kuk JL, Ardern CI, Church TS, et al. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab. 2011;36(4):570–6.

    Article  Google Scholar 

  4. Padwal RS, Pajewski NM, Allison DB, et al. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183(14):E1059–66.

    Article  Google Scholar 

  5. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.

    Article  Google Scholar 

  6. Schauer PR, Bhatt DL, Kashyap SR. Bariatric surgery or intensive medical therapy for diabetes after 5 years. N Engl J Med. 2017;376(20):1997.

    PubMed  Google Scholar 

  7. Angrisani L, Santonicola A, Iovino P, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783–94.

    Article  Google Scholar 

  8. Chiappetta S, Stier C, Squillante S, et al. The importance of the Edmonton Obesity Staging System in predicting postoperative outcome and 30-day mortality after metabolic surgery. Surg Obes Relat Dis. 2016;12(10):1847–55.

    Article  Google Scholar 

  9. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.

    Article  Google Scholar 

  10. DeMaria EJ, Murr M, Byrne TK, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg. 2007;246(4):578–82. discussion 83-4

    Article  Google Scholar 

  11. Blackstone RP, Cortes MC. Metabolic acuity score: effect on major complications after bariatric surgery. Surg Obes Relat Dis. 2010;6(3):267–73.

    Article  Google Scholar 

  12. Fischer L, Nickel F, Sander J, et al. Patient expectations of bariatric surgery are gender specific--a prospective, multicenter cohort study. Surg Obes Relat Dis. 2014;10(3):516–23.

    Article  Google Scholar 

  13. Seetharamaiah S, Tantia O, Goyal G, et al. LSG vs OAGB-1 year follow-up data-a randomized control trial. Obes Surg. 2017;27(4):948–54.

    Article  Google Scholar 

  14. Quan Y, Huang A, Ye M, et al. Efficacy of laparoscopic mini gastric bypass for obesity and type 2 diabetes mellitus: a systematic review and meta-analysis. Gastroenterol Res Pract. 2015;2015:152852.

    Article  Google Scholar 

  15. Lee WJ, Chong K, Lin YH, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014;24(9):1552–62.

    Article  Google Scholar 

  16. Taha O, Abdelaal M, Abozeid M, et al. Outcomes of omega loop gastric bypass, 6-years experience of 1520 cases. Obes Surg. 2017;27(8):1952–60.

    Article  Google Scholar 

  17. Zhu M, Wang Q, Luo Z, et al. Development and validation of a prognostic signature for preoperative prediction of overall survival in gastric cancer patients. Oncol Targets Ther. 2018;11:8711–22.

    Article  CAS  Google Scholar 

  18. Aminian A, Brethauer SA, Andalib A, et al. Individualized metabolic surgery score: procedure selection based on diabetes severity. Ann Surg. 2017;266(4):650–7.

    Article  Google Scholar 

  19. Stroh C, Kockerling F, Volker L, et al. Results of more than 11,800 sleeve gastrectomies: data analysis of the German bariatric surgery registry. Ann Surg. 2016;263(5):949–55.

    Article  Google Scholar 

  20. El-Sayes IA, Frenken M, Weiner RA. Management of leakage and stenosis after sleeve gastrectomy. Surgery. 2017;162(3):652–61.

    Article  Google Scholar 

  21. Tolone S, Cristiano S, Savarino E, et al. Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Relat Dis. 2016;12(1):62–9.

    Article  Google Scholar 

  22. Peterli R, Wolnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.

    Article  Google Scholar 

  23. Nguyen NT, Nguyen B, Nguyen VQ, et al. Outcomes of bariatric surgery performed at accredited vs nonaccredited centers. J Am Coll Surg. 2012;215(4):467–74.

    Article  Google Scholar 

  24. Nguyen NT, Paya M, Stevens CM, et al. The relationship between hospital volume and outcome in bariatric surgery at academic medical centers. Ann Surg. 2004;240(4):586–93. discussion 93-4

    PubMed  PubMed Central  Google Scholar 

  25. Daigle CR, Brethauer SA, Tu C, et al. Which postoperative complications matter most after bariatric surgery? Prioritizing quality improvement efforts to improve national outcomes. Surg Obes Relat Dis. 2018;14(5):652–7.

    Article  Google Scholar 

  26. Zafar SN, Miller K, Felton J, et al. Postoperative bleeding after laparoscopic Roux en Y gastric bypass: predictors and consequences. Surg Endosc. 2019;33(1):272–80.

    Article  Google Scholar 

  27. Quirante FP, Montorfano L, Rammohan R, et al. Is bariatric surgery safe in the elderly population? Surg Endosc. 2017;31(4):1538–43.

    Article  Google Scholar 

  28. Khidir N, El-Matbouly M, Al Kuwari M, et al. Incidence, indications, and predictive factors for ICU admission in elderly, high-risk patients undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2018;28(9):2603–8.

    Article  Google Scholar 

  29. Felsenreich DM, Ladinig LM, Beckerhinn P, et al. Update: 10 years of sleeve gastrectomy-the first 103 patients. Obes Surg. 2018;28(11):3586–94.

    Article  Google Scholar 

  30. Sebastianelli L, Benois M, Vanbiervliet G, et al. Systematic endoscopy 5 years after sleeve gastrectomy results in a high rate of Barrett’s esophagus: results of a multicenter study. Obes Surg. 2019;29(5):1462–9.

    Article  Google Scholar 

  31. Musella M, Susa A, Manno E, et al. Complications following the mini/one anastomosis gastric bypass (MGB/OAGB): a multi-institutional survey on 2678 patients with a mid-term (5 years) follow-up. Obes Surg. 2017;27(11):2956–67.

    Article  Google Scholar 

  32. Baig SJ, Priya P, Mahawar KK, et al. Indian bariatric surgery outcome reporting G. weight regain after bariatric surgery-a multicentre study of 9617 patients from Indian bariatric surgery outcome reporting group. Obes Surg. 2019;29(5):1583–92.

    Article  Google Scholar 

Download references

Acknowledgments

This work has been conducted using the StuDoQ|MBE registry provided by the Study, Documentation and Quality Center (Studien-, Dokumentations- und Qualitätszentrum, StuDoQ) of the German Society for General Surgery (Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie, DGAV) with the ID StuDoQ-2017-0019.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Sonja Chiappetta.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Statement of Human and Animal Rights

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Statement of Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chiappetta, S., Stier, C., Weiner, R.A. et al. The Edmonton Obesity Staging System Predicts Perioperative Complications and Procedure Choice in Obesity and Metabolic Surgery—a German Nationwide Register-Based Cohort Study (StuDoQ|MBE). OBES SURG 29, 3791–3799 (2019). https://doi.org/10.1007/s11695-019-04015-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-019-04015-y

Keywords

Navigation